Cardiac conduction system INPP5K Laminopathie Regeneration CRISPR Calcium handling POPDC1 Ehlers‐Danlos Syndrome Congenital muscular dystrophy Dilated cardiomyopathy Clinical trial Angiotensin-converting enzyme inhibitors Muscle MRI BVES Alternative splicing Lamin A/C Maladies rares et orphelines Becker muscular dystrophy Angiotensin-converting enzyme inhibitor Allele‐specific silencing therapy AAV VECTOR Mouse Emerin LMNA GNE Nuclear envelope Biomarker Gene therapy C2C12 IPSC Cardiomyopathy Dynamin 2 Adult SMA Titin CSF protein COL6A1 Lamins Cancer Myogenesis Mutations AAV Skeletal muscle LMNA-related congenital muscular dystrophy Lamin A/C nuclei Hypermobile EDS Treatment delay Heart Base de données FAIR COVID-19 Connective tissue Treatment COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders CMTX Muscular dystrophy Actionability RNA interference Centronuclear myopathy Lamin A/C LMNA gene COL1A1 Next generation sequencing Myologie Duchenne muscular dystrophy Myopathy Joint laxity LMNA gene Allele-specific silencing Muscular dystrophy MD Cardiology Laminopathies Laminopathy A-type lamin Muscle biopsy Rare diseases Autophagosome maturation Dystrophie musculaire Emery-Dreifuss muscular dystrophy A-type lamins Myotubes BiP Neuromuscular diseases Myopathies Actionable gene Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Diagnosis Rare neuromuscular diseases Therapy Patient registry Dystrophine Errance diagnostique LGMD Maladies rares Butyrylcholinesterase Cancer biomarkers Exome Acetyltransferase Muscle Biological sciences Heart failure Allele-specific silencing therapy C elegans